[Correlation between kynurenine metabolites and postpartum depression]

Area of Science:

• Biochemistry
• Neuroscience
• Psychiatry

Background:

• Postpartum depression (PPD) is a significant concern affecting maternal mental health.
• The pathogenesis of PPD remains incompletely understood, necessitating exploration of novel biological markers.
• Kynurenine (KYN) pathway metabolites have been implicated in various neurological and psychiatric conditions.

Purpose of the Study:

• To investigate the correlation between serum concentrations of kynurenine (KYN) metabolites and the incidence of postpartum depression (PPD).
• To explore the potential role of KYN, quinolinic acid (QUIN), and kynurenic acid (KYNA) in the pathogenesis of PPD.
• To identify potential new therapeutic strategies for PPD based on metabolite alterations.

Main Methods:

• A cohort of 726 Chinese women undergoing cesarean section was studied.
• PPD was diagnosed using the Edinburgh Postnatal Depression Scale (EPDS) with a score ≥13.
• Serum concentrations of KYN, QUIN, and KYNA were measured in 24 women with PPD and 48 matched controls at specific postpartum time points.

Main Results:

• The incidence of PPD in the study cohort was 7.99%.
• Women with PPD exhibited significantly increased serum KYN at the end of term, and increased QUIN and decreased KYNA on day 3 postpartum compared to controls.
• The KYNA/QUIN ratio was significantly higher in women with PPD on day 3 postpartum.

Conclusions:

• Alterations in plasma levels of KYN, QUIN, and KYNA are closely associated with the occurrence of PPD.
• The ratio of KYNA/QUIN may serve as a potential biomarker for PPD.
• Modulating the KYNA/QUIN ratio could represent a novel preventative and therapeutic approach for postpartum depressive symptoms.